Will Hope Lead to Pain Once Again?<br />By Rev Shark<br />RealMoney.com Contributor<br />8/6/2008 8:36 AM EDT <br /><br />A leader is a dealer in hope. <br />-- Napoleon Bonaparte<br /><br />There is an old saying that in a bear market we slide down a slope of hope. It is those big spikes of hope that the worst is over that inevitably lead to the next wave of selling. <br /><br />The psychology of a bear market is a cycle of hope and disappointment, with each new disappointment creating more despair and pessimism, until eventually we reach the point where all hope is finally wrung out of the market and we can bottom. The process can take quite a long time to play out, and what makes it so difficult to deal with is the many false bottoms that occur. Market players are always anxious to believe that their nightmare has finally ended and things will once again to uptrend. <br /><br />Yesterday we had a very classic spike of hope. Lower crude oil prices and an inactive Fed supported it, but that rationale seems a bit strained given the overall economic environment. Nonetheless, market players want to hope that we can at least get a rally, and they made it a self-fulfilling prophecy to some extent. <br /><br />At some point, "hope" will prove to be the correct investment approach. It might even be this time. The technical conditions are better, and we have some indications we can work higher from here, but the macroeconomic environment and seasonality favor the bears. <br /><br />After the big point move yesterday, the bulls have the advantage and can prove that they are something more than naïve optimists by putting up more money to support this market. If profit-taking kicks in quickly instead, and dip-buyers show little interest, we will know that this is yet another slippery slope of hope that will cost us if we are too trusting. <br /><br />We have a mixed start to kick off the morning. Freddie Mac (FRE) earnings were poor, but Cisco (CSCO) is getting a boost on slightly better-than-expected numbers and reduced estimates. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: MWA +14.8%, GGC +11.8%, MDRX +11.3%, KNDL +9.6%, FTK +9.5% (light volume), AMKR +9.4%, HDSN +9.1%, BIDZ +8.8%, TKLC +7.8%, OPWV +7.7%, HLS +6.9%, ONNN +6.0%, CSCO +5.6% (also assumed with an Equal Weight at Lehman, down from prior Overweight rating), ABK +4.9%, ACAS +4.7% (light volume), RL +4.1%, HLF +3.2%, FWLT +2.8%, WBMD +2.7% (also upgraded to Source of Funds at ThinkPanmure), USU +2.6% (light volume), PZZA +1.4% (light volume)... Select metals/mining names showing strength: RTP +4.6%, AAUK +4.6%, BBL +3.7%, BHP +3.5%, LMC +3.5%, PAL +2.4%, GG +2.3%, GFI +1.9%... Other news: ILE +303.4% (reports positive top-line results from pivotal phase III studies of Isolagen Therapy in wrinkles; studies meet all primary efficacy endpoints and are statistically significant), VRNM +48.5% (Verenium and BP announce partnership to accelerate the commercialization of cellulosic ethanol; also upgraded to Buy at Jefferies), SCA +39.3% (XL Capital announces closing of previously announced transactions with Security Capital Assurance Ltd and capital raise), DVAX +14.9% (Dynavax Technologies and Merck announce Phase 3 Trial with Investigational Hepatitis B vaccine Heplisav met its primary endpoint), IOC +9.1% (advises that testing has shown an excellent gas flow at the Elk-4 discovery well), HOKU +7.6% (HOKU Scientific and Tianwei sign $284 mln Polysilicon supply contract), S +2.3% (announces proposed private placement of $3 bln of cumulative perpetual convertible preferred stock), BP +1.3% (still checking)... Analyst comments: LLNW +7.7% (upgraded to Buy at Jefferies), FCX +3.5% (added to Top Picks Live List at Citigroup), SLW +2.7% (upgraded to Outperform at Raymond James), HMA +2.2% (upgraded to Outperform at Leerink Swann).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: INAP -26.9% (also downgraded to Perform at Oppenheimer), ABCO -25.3% (also downgraded to Perform at Oppenheimer), MFLX -21.4%, KMX -19.4%, WFMI -18.8% (also downgraded to Source of Funds at ThinkPanmure), PCLN -17.6%, KOG -16.5%, EAC -16.2%, MVIS -13.9%, SNCR -10.9%, BMRN -10.0%, AKNS -8.7%, S -7.6% (also announces a 3 mln share cumulative perpetual convertible preferred stock private placement offering), HSP -6.9%, FRE -6.7%, QSFT -6.3%, SMSI -5.4%, ALSK -4.9% (light volume), PACR -4.9% (also downgraded to Underweight at JPMorgan), MOLX -3.3%, LTRE -2.3% (light volume), DRRX -2.2% (light volume), WMS -2.2%, MSCS -2.0%, SKYW -1.6%, AREX -1.3% (light volume), JCOM -1.2%, MCHX -1.0% (also downgraded to Accumulate from Buy at ThinkPanmure)... Select mortgage/financial stocks trading lower: FNM -7.8% (down in sympathy with FRE), LYG -5.6% (trading ex-dividend), LEH -4.2%, IBN -3.7%, WM -2.9%, BCS -2.8%, WB -2.4%, WFC -1.9%, C -1.6% (talks with regulators may bring billions in auction-rate-securities buybacks - WSJ), MER -1.6%, HBC -1.6%, JPM -1.4%... Other news: HCP -7.4% (announces a 13 mln share common stock secondary offering), MEE -5.9% (files for mixed securities shelf offering), SHPGY -3.4%, SI -1.8% (still checking), EXPE -1.1% (trading down in sympathy with PCLN)... Analyst comments: NVS -3.4% (downgraded to Neutral at JPMorgan), BIG -2.7% (downgraded to Hold at Soleil), VRTX -2.4% (downgraded to Neutral from Positive at Susquehanna), AIG -1.6% (initiated with Sell at Societe Generale - Bloomberg), SONC -1.1% (downgraded to Sell at Merrill).